Analysis

Briefings

Subscribe to Briefings

Update on Consolidation in the Life Industry

Thursday 1st April 1999

Corporate "Gene Giants" are expanding market share over agribusiness, food and pharmacy. Market dominance combined with monopoly patents gives the Gene Giants unprecedented control over the products and processes of life - the biological basis for commercial food, farming and health.

The Terminator's Wider Implications

Monday 1st February 1999

RAFI examines the broader implications of Terminator and Traitor technologies. Traitor Tech refers to a new array of patents describing the control of a plant's genetic traits by the application of an external chemical catalyst. Farmers are becoming trapped in a pattern of biological controls that inevitably lead to bioserfdom.

Tuesday 15th December 1998

The Novartis patents comprise a wide-ranging and inter-related group directed toward controlled expression of desired traits in plants, these resulting from introduction of DNA constructs. While a principal focus of the work is to regulate gene expression by exposure of the plant to chemicals that can activate the promoter regions of introduced genes, the work also includes constructs that confer the constitutive expression (i.e. maintained in the absence of external stimulus) of introduced traits. In addition, considerable effort has been devoted to isolating the gene products which are produced as a stress response by the plants. Isolation of the genes that code for these proteins, and of the promoter sequences which regulate their expression, provide the basis for much of the work. Several of the claims are methodological, defining ways of isolating desired genes and the promoters that control them, but essentially they are variants of themes already well-developed in biotechnology. Similarly, while there is considerable space given in the discussion to the methods of transforming the plants through introduction of DNA sequences, the approaches used are standard for the industry and not relevant to understanding the result.

RAFI's Seed Industry Consolidation Chart

Saturday 1st August 1998

The first half of 1998 witnessed a dramatic consolidation of power over plant genetics worldwide. The global seed trade is dominated by life industry giants whose vast economic power over plant germplasm has effectively marginalized the role of public sector plant breeding and research.

New Genetic Technology Aims to Prevent Farmers from Saving Seed

Wednesday 1st April 1998

RAFI's first publication alerting the world to Terminator technology - published just weeks after RAFI discovered the patent. On March 3, 1998 the US Department of Agriculture and an American cotton seed company, Delta & Pine Land Co., received a US patent on a technique that genetically alters seed so that it will not germinate if re-planted a second time. It is a global threat the farmers, biodiversity and food security.

UPOV Buries it Head; PBR Moratorium Page

Sunday 1st February 1998

RAFI's study of 118 Plant Breeders' Rights claims exposes a predatory pattern of biopiracy supported by UPOV and by national legislation in several OECD countries, especially Australia.

The global enterprises that dominate commercial agriculture, food and health

Monday 1st December 1997

In 1997, for the first time in history, global mergers and acquisitions topped 1 trillion dollars - almost 10 times the value of all takeovers at the outset of this decade. UNCTAD revealed that 79% of all foreign direct investment to the South is now in the form of corporate acquisitions and a parallel US government report advises that 40-45% of all manufacturing sales are between subsidiary and parent multinationals. 1 The multilateral agreement on investment (MAI) currently being negotiated by industrialized countries behind closed doors, if adopted, could be the final blow to national sovereignty and signal the de facto ascendancy of transnational enterprises to the political control of the world's economy. During 1997, the life industry was also active in consolidating its power over the world's biological resources...

*The world's top 10 agrochemical corporations accounted for 82% of the global agrochemical sales in 1996. Sales reached US $30.5 billion last year, up more than 15% since 1994.

*The top 10 seed corporations control approximately 40% of the commercial seed market, valued at approximately (US) $15 billion.

*The world pharmaceutical market is an estimated $251 billion; the top 10 enterprises control approximately 36% of the global market. The top 20 drug companies control 57%.

*By the end of 1997, the top 10 veterinary medicine corporations are expected to hold 63% of the total worldwide market.

Monday 1st December 1997

The Life Industry 1997: The Global Enterprises that Dominate Commercial Agric., Food, and Health in 1997 - an overview

HGDP Rejected

Wednesday 1st October 1997

The life industry and US government are using bilateral bioprospecting agreements as their tool of choice to cheaply access genetic resources and undervalue farmers' resources and knowledge. These bilaterial agreements actually encourage inequities through patents, secrecy, and imbalanced negotiations that favour companies, not the true innovators and sustainable users of diversity, farmers and indigenous people.

Friday 1st August 1997

The world's largest and most influential international agricultural research network, the Consultative Group on International Agricultural Research (CGIAR), is conducting its first full systemwide review in 17 years. In May, 1998 in Brayil, a prestigious review panel led by Maurice Strong will table its recommendations for the future of the network, which launched the Green Revolution.

Pages

For content related to the specific item being viewed or tasks at hand e.g. "Similar content" and search results

 

 

Subscribe to Briefings Subscribe to Reports